Safety alerts, recalls, shortages, labeling changes, and medication warnings from trusted authorities.
The FDA recall covers one lot of Beekeeper’s Naturals Saline Nasal Spray sold through Amazon: lot 5950, best by 02/2028. Here’s how to check your bottle, who may be at higher risk, and when symptoms deserve medical attention.
CDC says benzathine penicillin G remains the only recommended treatment for syphilis during pregnancy. Here is what the temporary import of Lentocilin changes, what stays the same, and what pregnant patients can ask about now.
If Bicillin L-A is unavailable during pregnancy, ask your obstetric or prescribing team for a same-day plan. CDC says penicillin remains the only recommended treatment for syphilis during pregnancy, and FDA has allowed temporary imported supply during the shortage.
A June 2026 recall of Nara Organics infant formula is tied to a botulism outbreak. Here is what parents should do now and which symptoms need urgent care.
The FDA says certain Omnipod 5, Omnipod DASH, and Omnipod Eros pods may under-deliver insulin because of a tubing defect. Here is how to check lot numbers, what warning signs to watch for, and when high blood sugar becomes an emergency.
FDA added a new kidney warning to over-the-counter alli on June 10, 2026. This was a label update, not a recall. People with a history of kidney disease or kidney stones should read the label carefully and know the symptoms that mean they should stop using the drug and get medical advice.
If you use a TRUE METRIX glucose meter, the FDA says not to stop checking your blood sugar before you have another testing method available. Here is what the E-5 error means, who should try to switch first, and when symptoms need urgent care.
A new FDA-posted safety action affects specific lots of Omnipod 5, DASH, and Eros pods. Here’s how to check yours, spot possible insulin under-delivery, and know when high blood sugar may be an emergency.
FDA says one lot of MG217 eczema cream was recalled after Staphylococcus aureus contamination was found. Here is how to check your tube, why eczema patients may face higher risk, and what symptoms should prompt medical care.
FDA posted a Dexcom safety notice on May 29 after the company said two stolen G7 sensor lots entered the U.S. market. Here is how to check your lot number, when backup fingerstick checks matter, and which symptoms need prompt care.
Federal health officials say a multistate Salmonella outbreak is tied to recalled moringa supplement products. Here’s what was recalled, who may be at higher risk, and what to do if the products are in your home.
The FDA now says all carbidopa/levodopa products need a warning about vitamin B6 deficiency and seizures. For people with Parkinson’s disease, the practical takeaway is to know the symptoms, avoid abrupt medicine changes, and ask a clinician whether vitamin B6 monitoring makes sense.
B. Braun Medical has recalled specific lots of Lactated Ringer’s Injection, 1L, after FDA said the product may contain particulate matter. The recall affects hospitals and other healthcare facilities; patients who recently received this IV fluid can ask their care team whether the recalled lots were used.
The FDA added neurosurgical patties to its medical device shortage list on May 6, 2026. For patients, that does not automatically mean care is being delayed, but it does signal that hospitals and surgical teams may need to plan around tighter supply and use available stock carefully.
The FDA says people using TRUE METRIX blood glucose systems should keep testing for now, but should transition to another meter when possible. The concern is an E-5 error code that can be confused with either a very high glucose reading or a test strip problem, which could delay the right response.
A nationwide hospital-level recall is underway for one lot of magnesium sulfate after FDA said a pouch was found to contain tranexamic acid instead. The issue matters because both drugs are used in urgent care, but FDA said it had not received adverse-event reports at the time of the announcement.
The FDA has proposed removing semaglutide, tirzepatide, and liraglutide from a key bulk-substance list used by outsourcing compounding facilities. The move follows the agency’s view that national GLP-1 supply has stabilized and that the shortage-driven flexibility is no longer needed.
The FDA has issued two separate safety notices that may affect hospitals and patients: a nationwide recall of certain B. Braun Lactated Ringer’s Injection 1L lots because of particulate matter, and a shortage notice for neurosurgical patties, sponges and strips. The actions are different, but both can affect procedure planning, supply checks and patient safety.
A recall is not the same as a shortage. One means a product may be unsafe or defective; the other means supply is limited or disrupted. The latest FDA updates include a May 6 device shortage addition, an April 28 recall of lactated Ringer’s injection, and new reminders about how GLP-1 supply changes affect compounded versions.
Two recent FDA notices involving injectable medicines are a reminder that hospital IV recalls are usually specific, lot-based safety actions — not a signal that every product in a category is unsafe. The latest alerts involve a magnesium sulfate mix-up and lactated Ringer’s solution with particulate matter.
The FDA says a shortage of neurosurgical patties, sponges, and strips may continue through the end of 2026. The agency is asking hospitals and surgical teams to conserve supplies, prioritize essential cases, and plan for alternatives when appropriate.
The FDA is proposing new limits on compounded versions of semaglutide, tirzepatide, and liraglutide as national supply conditions improve. The change would not take effect immediately, and access could still vary by pharmacy, state rules, and insurance coverage.
End of content
End of content